Jl. Delassus et al., Comparison of AZT+3TC+Nevirapine and D4T+DDI+Nevirapine in naive patients during 52 weeks, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 77-80
Compare the efficacy and the tolerance of two treatments associating two NR
TI and one NNRTI (Nevirapine). in naive patients HIV infected, with a follo
w up of one year.
Twenty patients, two homogeneous groups, AZT+3TC+Nevirapine versus D4T+DDINevirapine 70% undetectable patients at W52, in each group, with Chiron tes
t 500 copys/ml. The CD4 mean increment is more important in the group D4T+D
DI+Nevirapine. The long term use of 2 NRTI+1 NNRTI in naive patients positi
ve for the future.